Literature DB >> 447888

Decreased locomotor and investigatory exploration after denervation of catecholamine terminal fields in the forebrain of rats.

J S Fink, G P Smith.   

Abstract

Exploratory behaviors were examined after bilateral microinjections of 6-hydroxydopamine into two hypothalamic sites that produced different patterns of denervation of forebrain catecholamine terminal fields. After anterolateral injections rats locomoted and reared less in a novel open field, responded abnormally to changes in the degree of novelty of the open field, and investigated a novel object less. These are deficits in exploratory behavior because they were not secondary to the inhibition of open-field behavior by hyperemotionality, by general motor disability, or by the failure to detect novel spaces or objects. Such anterolateral injections produced loss of catecholamine fibers, determined histochemically, in neocortical, hippocampal, anterolateral hypothalamic, mesolimbic, mesocortical, and anteromedioventral striatal terminal fields and loss of dopaminergic perikarya in the A10 and anteromedial A9 cell groups. No deficits in exploratory behaviors occurred, however, after bilateral anteromedial 6-hydroxydopamine injections that denervated neocortical, hippocampal, and anteromedial hypothalamic catecholamine terminal fields. A critical forebrain catecholaminergic innervation for exploratory responses to novel stimuli may be within areas that were denervated by anterolateral but not by anteromedial hypothalamic 6-nydroxydopamine injections. These areas are mesolimbic, mesocortical, anteromedioventral, and anterolateral hypothalamic terminal fields.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 447888     DOI: 10.1037/h0077587

Source DB:  PubMed          Journal:  J Comp Physiol Psychol        ISSN: 0021-9940


  8 in total

1.  Environmental enrichment decreases responding for visual novelty.

Authors:  Mary E Cain; Thomas A Green; Michael T Bardo
Journal:  Behav Processes       Date:  2006-09-20       Impact factor: 1.777

2.  Dopaminergic agonists differentially affect open-field activity of rats with A10 lesions.

Authors:  G K Hodge; M G Boyeson; R T Linn
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

3.  Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli.

Authors:  M T Bardo; S L Bowling; R C Pierce
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment.

Authors:  V Bruto; C Beauchamp; R M Zacharko; H Anisman
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats.

Authors:  T Peeyush Kumar; Sherin Antony; G Gireesh; Naijil George; C S Paulose
Journal:  J Biomed Sci       Date:  2010-05-31       Impact factor: 8.410

6.  Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.

Authors:  M E Olds; J L Fobes; V Albert
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Posterior ventral tegmental area-nucleus accumbens shell circuitry modulates response to novelty.

Authors:  Hailong Li; Jessica M Illenberger; Michael N Cranston; Charles F Mactutus; Kristen A McLaurin; Steven B Harrod; Rosemarie M Booze
Journal:  PLoS One       Date:  2019-03-05       Impact factor: 3.240

8.  Amphetamine administration into the ventral striatum facilitates behavioral interaction with unconditioned visual signals in rats.

Authors:  Rick Shin; Junran Cao; Sierra M Webb; Satoshi Ikemoto
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.